Quick Answer
Stereotaxis, Inc. reported Total Revenue of $32.38 million for fiscal year 2025.
Stereotaxis, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $32.38M +20.3% |
$26.92M +0.5% |
$26.77M -4.9% |
$28.15M -19.6% |
$35.02M +31.5% |
$26.63M -7.9% |
| Revenue (ASC 606) | $32.38M +20.3% |
$26.92M +0.5% |
$26.77M -4.9% |
$28.15M -19.6% |
$35.02M +31.5% |
$26.63M -7.9% |
| Net Income | -$21.64M +10.0% |
-$24.05M -16.1% |
-$20.71M -13.2% |
-$18.29M -70.7% |
-$10.72M -61.2% |
-$6.65M -44.8% |
| Diluted EPS | -$0.25 +16.7% |
-$0.30 -11.1% |
-$0.27 -3.8% |
-$0.26 -62.5% |
-$0.16 -45.5% |
-$0.11 -10.0% |
| Total Assets | $52.25M +11.8% |
$46.72M +11.5% |
$41.91M -21.5% |
$53.41M -12.4% |
$60.98M +10.0% |
$55.46M +27.2% |
| Cash and Equivalents | $13.42M +9.9% |
$12.22M -38.4% |
$19.82M +130.8% |
$8.59M -77.8% |
$38.74M -11.8% |
$43.94M +45.6% |
| Long-Term Debt | — | — | — | — | — | $973.3K |
| Stockholders Equity | $13.48M +121.7% |
$6.08M -62.8% |
$16.34M -38.0% |
$26.35M -22.1% |
$33.84M -2.3% |
$34.62M +52.1% |
| R&D Expense | $9.38M -3.9% |
$9.76M -5.0% |
$10.27M -2.7% |
$10.56M +3.5% |
$10.20M +25.3% |
$8.14M -9.8% |
| Operating Income | -$22.11M +10.6% |
-$24.74M -13.3% |
-$21.84M -16.3% |
-$18.78M -45.7% |
-$12.89M -92.0% |
-$6.71M -39.1% |
| Gross Profit | $17.07M +17.0% |
$14.59M -1.8% |
$14.86M -19.5% |
$18.47M -20.5% |
$23.23M +22.5% |
$18.97M -16.7% |
| Shares Outstanding | — | — | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $7.46M | -18.8% | -15.2% |
| Revenue (ASC 606) | September 30, 2025 | $7.46M | -18.8% | -15.2% |
| Net Income | September 30, 2025 | -$6.46M | -4.4% | -68.9% |
| Diluted EPS | September 30, 2025 | -$0.07 | +12.5% | -40.0% |
| Total Assets | September 30, 2025 | $45.59M | -10.5% | +10.7% |
| Cash and Equivalents | September 30, 2025 | $10.51M | -1.5% | +50.8% |
| Long-Term Debt | March 31, 2021 | $243.6K | — | -75.0% |
| Stockholders Equity | September 30, 2025 | $6.27M | -42.1% | +330.4% |
| R&D Expense | September 30, 2025 | $2.55M | +3.7% | +43.3% |
| Operating Income | September 30, 2025 | -$6.56M | -3.3% | -64.9% |
| Gross Profit | September 30, 2025 | $4.10M | +0.0% | -10.4% |
| Shares Outstanding | September 30, 2013 | 15.93M | +103.7% | +91.4% |
- Stereotaxis, Inc. reported Total Revenue of $32.38 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +20.3% in Total Revenue compared to the prior fiscal year.
- Stereotaxis, Inc. reported Revenue (ASC 606) of $32.38 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +20.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Stereotaxis, Inc. reported Net Income of -$21.64 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +10.0% in Net Income compared to the prior fiscal year.
- Stereotaxis, Inc. reported Diluted EPS of $0.25 per share (loss) for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +16.7% in Diluted EPS compared to the prior fiscal year.
- Stereotaxis, Inc. reported Total Assets of $52.25 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +11.8% in Total Assets compared to the prior fiscal year.
- Stereotaxis, Inc. reported Cash and Equivalents of $13.42 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +9.9% in Cash and Equivalents compared to the prior fiscal year.
- Stereotaxis, Inc. reported Long-Term Debt of $973.3 thousand for fiscal year 2020.
- Stereotaxis, Inc. showed a decrease of -94.6% in Long-Term Debt compared to the prior fiscal year.
- Stereotaxis, Inc. reported Stockholders Equity of $13.48 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +121.7% in Stockholders Equity compared to the prior fiscal year.
- Stereotaxis, Inc. reported R&D Expense of $9.38 million for fiscal year 2025.
- Stereotaxis, Inc. showed a decrease of -3.9% in R&D Expense compared to the prior fiscal year.
- Stereotaxis, Inc. reported Operating Income of -$22.11 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +10.6% in Operating Income compared to the prior fiscal year.
- Stereotaxis, Inc. reported Gross Profit of $17.07 million for fiscal year 2025.
- Stereotaxis, Inc. showed an increase of +17.0% in Gross Profit compared to the prior fiscal year.
- Stereotaxis, Inc. reported Shares Outstanding of 8.02 million shares for fiscal year 2012.
- Stereotaxis, Inc. showed an increase of +44.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: